Kennedy Capital Management Inc. Has $3.27 Million Holdings in Endo International PLC (ENDP)

Kennedy Capital Management Inc. raised its stake in shares of Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 293,042 shares of the company’s stock after purchasing an additional 593 shares during the period. Kennedy Capital Management Inc. owned 0.13% of Endo International PLC worth $3,273,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Jensen Investment Management Inc. grew its holdings in Endo International PLC by 24.2% during the second quarter. Jensen Investment Management Inc. now owns 30,620 shares of the company’s stock valued at $342,000 after purchasing an additional 5,960 shares during the last quarter. River & Mercantile Asset Management LLP acquired a new position in Endo International PLC during the second quarter valued at approximately $1,851,000. Airain ltd acquired a new position in Endo International PLC during the second quarter valued at approximately $387,000. Point View Wealth Management Inc. grew its stake in shares of Endo International PLC by 16.6% in the second quarter. Point View Wealth Management Inc. now owns 13,331 shares of the company’s stock worth $149,000 after acquiring an additional 1,900 shares during the last quarter. Finally, Blair William & Co. IL acquired a new stake in shares of Endo International PLC in the second quarter worth $126,000. Institutional investors own 90.71% of the company’s stock.

In other Endo International PLC news, CFO Blaise Coleman acquired 6,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was acquired at an average cost of $7.89 per share, for a total transaction of $51,285.00. Following the transaction, the chief financial officer now directly owns 13,729 shares in the company, valued at $108,321.81. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Terrance J. Coughlin acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The shares were acquired at an average price of $7.70 per share, with a total value of $154,000.00. Following the completion of the transaction, the chief operating officer now owns 181,369 shares in the company, valued at $1,396,541.30. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 36,000 shares of company stock valued at $279,460. 0.50% of the stock is owned by corporate insiders.

Several equities research analysts have recently issued reports on the stock. Piper Jaffray Companies restated a “hold” rating and issued a $9.00 price objective on shares of Endo International PLC in a research note on Sunday. Royal Bank Of Canada set a $9.00 price objective on shares of Endo International PLC and gave the stock a “hold” rating in a research note on Thursday, August 10th. Cowen and Company restated a “hold” rating and issued a $16.00 price objective on shares of Endo International PLC in a research note on Thursday, August 10th. Oppenheimer Holdings, Inc. restated a “hold” rating on shares of Endo International PLC in a research note on Tuesday, August 8th. Finally, Guggenheim assumed coverage on shares of Endo International PLC in a research note on Saturday, June 17th. They issued a “hold” rating and a $12.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, sixteen have given a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $14.33.

ILLEGAL ACTIVITY NOTICE: “Kennedy Capital Management Inc. Has $3.27 Million Holdings in Endo International PLC (ENDP)” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://sportsperspectives.com/2017/09/18/kennedy-capital-management-inc-has-3-27-million-holdings-in-endo-international-plc-endp.html.

Endo International PLC (ENDP) opened at 8.60 on Monday. The company has a 50 day moving average price of $8.88 and a 200-day moving average price of $10.89. The company’s market capitalization is $1.92 billion. Endo International PLC has a 12-month low of $7.41 and a 12-month high of $23.98.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last announced its quarterly earnings data on Tuesday, August 8th. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.19. Endo International PLC had a positive return on equity of 37.58% and a negative net margin of 126.93%. The business had revenue of $875.73 million during the quarter, compared to the consensus estimate of $832.66 million. During the same period in the prior year, the company earned $0.86 EPS. Endo International PLC’s revenue for the quarter was down 4.9% on a year-over-year basis. On average, analysts anticipate that Endo International PLC will post $3.52 EPS for the current year.

About Endo International PLC

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Institutional Ownership by Quarter for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply